1. Alving AS, Eichelberger L, Craige B, Jones R, Pullman TN, Whorton CM. A study of the prophylactic effect of several 8-amino quinolines including plasmochin for south pacific (chesson) vivax malaria. Journal of Clinical Investigation 1946;25:910-911.
2. Heidelberger M, Mayer M, Alving AS, Craige B, Jr., Jones R, Jr., Pullman TN, Whorton M. An attempt at vaccination of volunteers agains mosquito-borne infection with p. Vivax. Journal of Immunology 1946;53:113-118.
http://www.ncbi.nlm.nih.gov/pubmed/20985795
3. Heidelberger M, Mayer MM, Alving AS, Craig AS, Jones R, Pullman TN, Wharton M. Studies in human malaria. Iv. An attempt at vaccination of volunteers against mosquitoborne infection with pl. Vivax. Journal of Immunology 1946;53:113-118.
4. Pullman TN, Alving AS. Pentaquine (sn-13,276) a new antimalarial effective in reducing the relapse rate of vivax malaria. Proceedings [of the] annual meeting Central Society for Clinical Research (US) 1946;19:83.
http://www.ncbi.nlm.nih.gov/pubmed?term=20343588
5. Craige B, Alving AS. The chesson strain of plasmodium vivax malaria; relationship between prepatent period, latent period and relapse rate. Journal of Infectious Diseases 1947;80:228-236.
http://www.ncbi.nlm.nih.gov/pubmed/20247930
6. Craige B, Jr., Alving AS, Jones R, Jr., Whorton CM, Pullman TN, Eichelberger L. The chesson strain of plasmodium vivax malaria. Ii. Relationship between prepatent period, latent period and relapse rate. Journal of Infectious Diseases 1947;80:228-236.
7. Craige B, Jr., Jones R, Jr., Whorton CM, Pullman TN, Alving AS, Eichelberger L. Clinical standardization of pamaquin (plasmochin) in mosquito-induced vivax malaria, chesson strain. American Journal of Tropical Medicine 1947;27:300-315.
8. Whorton CM, Kirschbaum WR, Pullman TN, Jones R, Jr., Craige B, Jr., Alving AS, Eichelberger L, Coulston F. The chesson strain of plasmodium vivax malaria. I. Factors influencing the incubation period. Journal of Infectious Diseases 1947;80:223-227.
9. Whorton CM, Pullman TN, Kirschbaum WR, Jones R, Jr., Alving AS, Craige B, Jr., Eichelberger L, Coulston F. The chesson strain of plamodium vivax malaria. Iv. Immunity J inf Dis Chicago 1947;81:1-6.
10. Whorton CM, Yount EJ, Jones R, Jr., Alving AS, Pullman TN, Craige B, Jr., Eichelberger L. The chesson strain of plasmodium vivax malaria. Iii. Clinical aspects. Journal of Infectious Diseases 1947;80:237-249.
11. Alving AS. Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria. Abstracts International Congress on Tropical Medicine and Malaria (4th : 1948 : Washington, D C) 1948;56:58.
12. Alving AS. Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria. Abstr Int Congr Trop Med Malar 1948;56:58.
http://www.ncbi.nlm.nih.gov/pubmed/18872928
13. Alving AS, Craige B. Pentaquine (sn-13,276) a therapeutic agent effective in reducing the relapse rate in vivax malaria. Journal of Clinical Investigation 1948;27:25-33.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438886/?tool=pmcentrez
14. Alving AS, Craige B. Procedures used at stateville penitentiary for the testing of potential antimalarial agents. Journal of Clinical Investigation 1948;27:2-5.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438882/?tool=pmcentrez
15. Alving AS, Eichelberger L, Craige B, Jones R, Whorton CM, Pullman TN. Studies on the chronic toxicity of chloroquine (sn-7618). Journal of Clinical Investigation 1948;27:60-65.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438891/?tool=pmcentrez
16. Alving AS, Pullman TN, Craige B, Jones R, Whorton CM, Eichelberger L. The clinical trial of eighteen analogues of pamaquin (plasmochin) in viv ax malaria (chesson strain). Journal of Clinical Investigation 1948;27:34-45.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438887/?tool=pmcentrez
17. Atchley JA, Yount EH. Reactions observed during treatment with pentaquine, administered with quinacrine (atabrine) metachloridine (sn-11,437) and with sulfadiazine. J Natl Malar Soc 1948;7:118-124.
http://www.ncbi.nlm.nih.gov/pubmed/18867814
18. Craige B, Eichelberger L, Jones R, Alving AS, Pullman TN, Whorton CM. The toxicity of large doses of pentaquine (sn-13,276), a new antimalarial drug. Journal of Clinical Investigation 1948;27:17-24.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438885/?tool=pmcentrez
19. Craige B, Whorton CM, Jones R, Pullman TN, Alving AS, Eichelberger L, Rothman S. A lichen-planus-like eruption occurring during the course of chloroquine administration. Journal of Clinical Investigation 1948;27:56-59.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438890/?tool=pmcentrez
20. Jones R, Craige B, Alving AS, Whorton CM, Pullman TN, Eichelberger L. A study of the prophylactic effectiveness of several 8-aminoquinolines in sporozoite-induced vivax malaria (chesson strain). Journal of Clinical Investigation 1948;27:6-11.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438883/?tool=pmcentrez
21. Jones R, Pullman TN, Whorton CM, Craige B, Alving AS, Eichelberger L. The therapeutic effectiveness of large doses of paludrine in acute attacks of sporozoite-induced viv ax malaria (chesson strain). Journal of Clinical Investigation 1948;27:51-55.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438889/?tool=pubmed
22. Pullman TN, Alving AS, Jones R, Whorton CM, Craige B, Eichelberger L. A study of the prophylactic, curative and suppressive activity of sn-11,437 (metachloridine) in standardized infections of vivax malaria. American Journal of Tropical Medicine 1948;28:413-423.
23. Pullman TN, Craige B. Comparison of chloroquine, quinacrine (atabrine) and quinine in the treatment of acute attacks of sporozoite-induced vivax malaria, chesson strain. Journal of Clinical Investigation 1948;27:46-50.
http://www.ncbi.nlm.nih.gov/pubmed/18860178
24. Pullman TN, Craige B, Alving AS, Whorton CM, Jones R, Eichelberger L. Comparison of chloroquine, quinacrine (atabrine), and quinine in the treatment of acute attacks of sporozoite-induced viv ax malaria (chesson strain). Journal of Clinical Investigation 1948;27:46-50.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438888/?tool=pmcentrez
25. Pullman TN, Eichelberger L. The use of sn-10,275 in the prophylaxis and treatment of sporozoite-induced vivax malaria, chesson strain. Journal of Clinical Investigation 1948;27:12-16.
http://www.ncbi.nlm.nih.gov/pubmed/18860174
26. Pullman TN, Eichelberger L, Alving AS, Jones R, Craige B, Whorton CM. The use of sn-10,275 in the prophylaxis and treatment of sporozoite-induced viv ax malaria (chesson strain). Journal of Clinical Investigation 1948;27:12-16.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438884/?tool=pmcentrez
27. Alving AS. The search for better antimalarial drugs. Am Prof Pharm 1950;16:241-247.
28. Edgcomb JH, Arnold J, Yount EH, Jr., Alving AS, Eichelberger L, Jeffery GM, Eyles D, Young MD. Primaquine, sn 13272, a new curative agent in vivax malaria; a preliminary report. Journal National Malaria Society 1950;9:285-292.
http://www.ncbi.nlm.nih.gov/pubmed/14804087
29. Alving AS, Arnold J, Robinson DH. Mass therapy of subclinical vivax malaria with primaquine. J Am Med Assoc 1952;149:1558-1562.
http://www.ncbi.nlm.nih.gov/pubmed/14945978
30. Alving AS, Arnold J, Robinson DH. Status of primaquine .1. Mass therapy of subclinical vivax malaria with primaquine. Jama-Journal of the American Medical Association 1952;149:1558-1562.
31. Clayman CB, Arnold J, Hockwald RS, Yount EH, Edgcomb JH, Alving AS. Toxicity of primaquine in caucasians. J Am Med Assoc 1952;149:1563-1568.
http://www.ncbi.nlm.nih.gov/pubmed/14945980
32. Garrison PL, Hankey DD, Coker WG, Donovan WN, Jastremski B, Coatney GR, Alving AS, Jones R. Cure of korean vivax malaria with pamaquine and primaquine. J Am Med Assoc 1952;149:1562-1563.
http://www.ncbi.nlm.nih.gov/pubmed/14945979
33. Garrison PL, Hankey DD, Coker WG, Donovan WN, Jastremski B, Coatney GR, Alving AS, Jones R. Status of primaquine .2. Cure of korean vivax malaria with pamaquine and primaquine. Jama-Journal of the American Medical Association 1952;149:1562-1563.
34. Hockwald RS, Arnold J, Clayman CB, Alving AS. Toxicity of primaquine in negroes. J Am Med Assoc 1952;149:1568-1570.
http://www.ncbi.nlm.nih.gov/pubmed/14945981
35. Alving AS, Hankey DD, Coatney GR, Jones R, Coker WG, Garrison PL, Donovan WN. Korean vivax malaria. Ii. Curative treatment with pamaquine and primaquine. Am J Trop Med Hyg 1953;2:970-976.
http://www.ncbi.nlm.nih.gov/pubmed/13104805
36. Coatney GR, Alving AS, Jones R, Hankey DD, Robinson DH, Garrison PL, Coker WG, Donovan WN, Di Lorenzo A, Marx RL, Simmons IH. Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg 1953;2:985-988.
http://www.ncbi.nlm.nih.gov/pubmed/13104808
37. Di Lorenzo A, Marx RL, Alving AS, Jones R. Korean vivax malaria. Iv. Curative effect of 15 milligrams of primaquine daily for 7 days. Am J Trop Med Hyg 1953;2:983-984.
http://www.ncbi.nlm.nih.gov/pubmed/13104807
38. Hankey DD, Jones R, Coatney GR, Alving AS, Coker WG, Garrison PL, Donovan WN. Korean vivax malaria .1. Natural history and response to chloroquine. American Journal of Tropical Medicine and Hygiene 1953;2:958-969.
39. Jones R, Jackson LS, Di Lorenzo A, Marx RL, Levy BL, Kenny EC, Gilbert M, Johnston MN, Alving AS. Korean vivax malaria. Iii. Curative effect and toxicity of primaquine in doses from 10 to 30 mg. Daily. Am J Trop Med Hyg 1953;2:977-982.
http://www.ncbi.nlm.nih.gov/pubmed/13104806
40. Thaeler AD, Arnold J, Alving AS. A clinical study of primaquine (s. N. 13,272) in the treatment of malaria among the miskito indians of nicaragua. Am J Trop Med Hyg 1953;2:989-999.
http://www.ncbi.nlm.nih.gov/pubmed/13104809
41. Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beutler E. Natural history of korean vivax malaria after deliberate inoculation of human volunteers. Journal of Laboratory and Clinical Medicine 1954;44:723-726.
http://www.ncbi.nlm.nih.gov/pubmed/13212248
42. Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Jeffery GM. The effect of continuous and intermittent primaquine therapy on the relapse rate of chesson strain vivax malaria. Journal of Laboratory and Clinical Medicine 1954;44:429-438.
http://www.ncbi.nlm.nih.gov/pubmed/13201852
43. Beutler E, Dern RJ, Alving AS. The hemolytic effect of primaquine. Iii. A study of primaquine-sensitive erythrocytes. Journal of Laboratory and Clinical Medicine 1954;44:177-184.
http://www.ncbi.nlm.nih.gov/pubmed/13184225
44. Beutler E, Dern RJ, Alving AS. The hemolytic effect of primaquine. Iv. The relationship of cell age to hemolysis. Journal of Laboratory and Clinical Medicine 1954;44:439-442.
http://www.ncbi.nlm.nih.gov/pubmed/13201853
45. Dern RJ, Beutler E, Alving AS. The hemolytic effect of primaquine. Ii. The natural course of the hemolytic anemia and the mechanism of its self-limited character. Journal of Laboratory and Clinical Medicine 1954;44:171-176.
http://www.ncbi.nlm.nih.gov/pubmed/13184224
46. Dern RJ, Weinstein IM, Leroy GV, Talmage DW, Alving AS. The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals. Journal of Laboratory and Clinical Medicine 1954;43:303-309.
http://www.ncbi.nlm.nih.gov/pubmed/13130947
47. Drug-induced hemolytic anemia. J Am Med Assoc 1955;158:310.
http://www.ncbi.nlm.nih.gov/pubmed/14367082
48. Alving AS, Arnold J, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. Journal of Laboratory and Clinical Medicine 1955;46:301-306.
http://www.ncbi.nlm.nih.gov/pubmed/13242948
49. Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL, Jeffery GM. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (panama, p-f-6 strain). Journal of Laboratory and Clinical Medicine 1955;46:391-397.
http://www.ncbi.nlm.nih.gov/pubmed/13252317
50. Beutler E, Dern RJ, Alving AS. The hemolytic effect of primaquine. Vi. An in vitro test for sensitivity of erythrocytes to primaquine. Journal of Laboratory and Clinical Medicine 1955;45:40-50.
http://www.ncbi.nlm.nih.gov/pubmed/13233626
51. Beutler E, Dern RJ, Flanagan CL. Effect of sickle-cell trait on resistance to malaria. Br Med J 1955;1:1189-1191.
http://www.ncbi.nlm.nih.gov/pubmed/14363831
52. Beutler E, Dern RJ, Flanagan CL, Alving AS. The hemolytic effect of primaquine. Vii. Biochemical studies of drug-sensitive erythrocytes. Journal of Laboratory and Clinical Medicine 1955;45:286-295.
http://www.ncbi.nlm.nih.gov/pubmed/13233657
53. Dern RJ, Beutler E, Alving AS. The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity. Journal of Laboratory and Clinical Medicine 1955;45:30-39.
http://www.ncbi.nlm.nih.gov/pubmed/13233625
54. Dern RJ, Beutler E, Arnold J, Lorincz A, Block M, Alving AS. Toxicity studies of pyrimethamine (daraprim). Am J Trop Med Hyg 1955;4:217-220.
http://www.ncbi.nlm.nih.gov/pubmed/14361899
55. Flanagan CL, Beutler E, Dern RJ, Alving AS. Biochemical changes in erythrocytes during hemolysis induced by aniline derivatives. Journal of Laboratory and Clinical Medicine 1955;46:814-814.
56. Alving AS, Carson PE, Flanagan CL, Ickes CE. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956;124:484-485.
http://www.ncbi.nlm.nih.gov/pubmed/13360274
57. Carson PE, Schrier SL, Alving AS. Inactivation of glucose-6-phosphate dehydrogenase in human erythrocytes. Journal of Laboratory and Clinical Medicine 1956;48:794-795.
58. Alving AS. Suppressive field therapy or treatment of acute attacks of clinical malaria. Current therapy. Philadelphia and London: W. B. Saunders Co.; 1957.
59. Carson P, Schrier S, Flanagan CL. Use of dpnh as coenzyme for glutathione reductase of hemolyzates. Federation Proceedings 1957;16:19-20.
60. Schrier S, Kellermeyer R, Carson P, Alving AS. A 2nd enzyme abnormality in primaquine sensitive erythrocytes. Journal of Laboratory and Clinical Medicine 1957;50:951-952.
61. Alving AS, Kellermeyer RW, Tarlov A, Schrier S, Carson PE. Biochemical and genetic aspects of primaquine-sensitive hemolytic anemia. Annals of Internal Medicine 1958;49:240-248.
http://www.ncbi.nlm.nih.gov/pubmed/13571815
62. Alving AS, Rucker K, Flanagan CL, Carson PE, Schrier SL, Kellermeyer RW, Tarlov AR. Observations on primaquine in the prophylaxis and cure of vivax malaria. Sixth International Congresses on Tropical Medicine and Malaria, Alving AS, Rucker K, Flanagan CL, Carson PE, Schrier SL, Kellermeyer RW, Tarlov AR, editors 7: 203-209, September 1958
63. Flanagan CL, Schrier SL, Carson PE, Alving AS. The hemolytic effect of primaquine. Viii. The effect of drug administration on parameters of primaquine sensitivity. Journal of Laboratory and Clinical Medicine 1958;51:600-608.
http://www.ncbi.nlm.nih.gov/pubmed/13525836
64. Kellermeyer RW, Tarlov AR, Schrier SL, Alving AS. Hemolytic effect of commonly used drugs on erythrocytes deficient in glucose-6-phosphate dehydrogenase. Journal of Laboratory and Clinical Medicine 1958;52:827-828.
65. Schrier SL, Kellermeyer RW, Alving AS. Coenzyme studies in primaquine-sensitive erythrocytes. Proceedings of the Society for Experimental Biology and Medicine 1958;99:354-356.
http://www.ncbi.nlm.nih.gov/pubmed/13601868
66. Schrier SL, Kellermeyer RW, Carson PE, Ickes CE, Alving AS. The hemolytic effect of primaquine. Ix. Enzymatic abnormalities in primaquine-sensitive erythrocytes. Journal of Laboratory and Clinical Medicine 1958;52:109-117.
http://www.ncbi.nlm.nih.gov/pubmed/13549855
67. Carson PE, Alving AS. The hemolytic state: Clinical and biochemical aspects of primaquine-sensitive hemolysis. The Pharmacologist 1959;1:46-47.
68. Carson PE, Schrier SL, Kellermeyer RW. Mechanism of inactivation of glucose-6-phosphate dehydrogenase in human erythrocytes. Nature 1959;184:1292-1293.
http://www.ncbi.nlm.nih.gov/pubmed/13807993
69. Schrier SL, Kellermeyer RW, Carson PE, Ickes CE, Alving AS. The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes. Journal of Laboratory and Clinical Medicine 1959;54:232-240.
http://www.ncbi.nlm.nih.gov/pubmed/14443591
70. Tarlov AR, Kellermeyer RW. Decreased catalase activity in primaquine sensitive erythrocytes. Federation Proceedings 1959;18:156-156.
71. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the chesson strain of piasmodium vivax by intermittent regimens of drug administration: A preliminary report. Bull World Health Organ 1960;22:621-631.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2555355/?tool=pmcentrez
72. Alving AS, Tarlov AR, Brewer G, Carson PE, Keller-Meyer RW, Long WK. Glucose-6-phosphate dehydrogenase deficiency: Some biological implications. Trans Assoc Am Physicians 1960;73:80-92.
http://www.ncbi.nlm.nih.gov/pubmed/13682838
73. Alving AS, Tarlov AR, Brewer GJ, Carson PE, Long WK. Glucose-6-phosphate dehydrogenase deficiency (primaquine sensitivity) - an inborn erro of metabolism. Proceedings of the VIIIth International Congress of Hematology, Alving AS, Tarlov AR, Brewer GJ, Carson PE, Long WK, editors 1108-1119, 1960
74. Brewer GJ, Tarlov AR, Alving AS. Methaemoglobin reduction test: A new, simple, in vitro test for identifying primaquine-sensitivity. Bull World Health Organ 1960;22:633-640.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2555344/?tool=pmcentrez
75. Brewer GJ, Tarlov AR, Kellermeyer RW. Role of methemoglobin in the mechanism of drug induced hemolysis associated with glucose-6-phosphate dehydrogenase deficiency. Journal of Laboratory and Clinical Medicine 1960;56:796-797.
76. Carson PE. Glucose-6-phosphate dehydrogenase deficiency in hemolytic anemia. Federation Proceedings 1960;19:995-1006.
http://www.ncbi.nlm.nih.gov/pubmed/13691105
77. Arnold J, Alving AS, Clayman CB. Induced primaquine resistance in vivax malaria. Trans R Soc Trop Med Hyg 1961;55:345-350.
http://www.ncbi.nlm.nih.gov/pubmed/13684386
78. Arnold J, Alving AS, Clayman CB. Induced primaquine resistance in vivax malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 1961;55:345-350.
79. Brewer GJ, Tarlov AR. Studies on the mechanism of primaquine-type hemolysis: The effect of methylene blue. Clin Res 1961;9:65.
80. Brewer GJ, Tarlov AR, Kellermeyer RW. Hemolytic effect of primaquine .12. Shortened erythrocyte life span in primaquine-sensitive male negroes in absence of drug administration. Journal of Laboratory and Clinical Medicine 1961;58:217-&.
81. Carson PE, Brewer GJ, Ickes C. Decreased glutathione reductase with susceptibility to hemolysis. Journal of Laboratory and Clinical Medicine 1961;58:804-&.
82. Carson PE, Long WK, Ickes CE. Activation of glutathione reductase (gssgr) in hemolyzates by stromata. Fed Proc 1961;20:64.
83. Kellermeyer RW, Carson PE, Schrier SL, Tarlov AR, Alving AS. The hemolytic effect of primaquine. Xiv. Pentose metabolism in primaquine-sensitive erythrocytes. Journal of Laboratory and Clinical Medicine 1961;58:715-724.
http://www.ncbi.nlm.nih.gov/pubmed/14454971
84. Kellermeyer RW, Tarlov AR, Schrier SL, Carson PE, Alving AS. The hemolytic effect of primaquine. Xiii. Gradient susceptibility to hemolysis of primaquine-sensitive erythrocytes. Journal of Laboratory and Clinical Medicine 1961;58:225-233.
http://www.ncbi.nlm.nih.gov/pubmed/13752331
85. Long WK, Carson PE. Increased erythrocyte glutathione reductase activity in diabetes mellitus. Biochemical and Biophysical Research Communications 1961;5:394-&.
86. Tarlov AR, Brewer GJ, Swanson SH. The effect of primaquine administration on the serum cholesterol of drug-sensitive american negroes. Clin Res 1961;9:190.
87. Tarlov AR, Kellermeyer RW. Hemolytic effect of primaquine .11. Decreased catalase activity in primaquine-sensitive erythrocytes. Journal of Laboratory and Clinical Medicine 1961;58:204-&.
http://www.ncbi.nlm.nih.gov/pubmed/13775336
88. Vivona S, Brewer GJ, Alving AS, Conrad M. Concurrent weekly administration of chloroquine and primaquine for prevention of korean vivax malaria. Bulletin of the World Health Organization 1961;25:267-&.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2555555/?tool=pmcentrez
89. Vivona S, Brewer GJ, Conrad M, Alving AS. The concurrent weekly administration of chloroquine and primaquine for the prevention of korean vivax malaria. Bull World Health Organ 1961;25:267-269.
http://www.ncbi.nlm.nih.gov/pubmed/13926331
90. Vivona S, Brewer GJ, Conrad M, Alving AS. The concurrent weekly administration of cholorquine and primaquine for the prevention of korean vivax malaria; 1961.
91. Alving AS, Powell RD, Brewer GJ, Arnold JD. Malaria, 8-aminoquinolines and haemolysis. Biological Council Symposium on Drugs, Parasites and Hosts, Alving AS, Powell RD, Brewer GJ, Arnold JD, editors 1962
92. Brewer GJ, Powell RD, Alving AS. Studies on mechanism of primaquine-type hemolysis - erythrocyte atp content and hexokinase activity. Journal of Laboratory and Clinical Medicine 1962;60:861-&.
93. Brewer GJ, Powell RD, Tarlov AR. Genetic implications of diisoproplyl fluorophosphate (dfp)32-erythrocyte survival studies in negro females heterozygous for glucose-6-phosphate dehydrogenase deficiency. Journal of Clinical Investigation 1962;41:1348-&.
94. Brewer GJ, Tarlov AR, Alving AS. The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis. JAMA 1962;180:386-388.
http://www.ncbi.nlm.nih.gov/pubmed/13872968
95. Brewer GJ, Tarlov AR, Kellermeyer RW, Alving AS. The hemolytic effect of primaquine. Xv. Role of methemoglobin. Journal of Laboratory and Clinical Medicine 1962;59:905-917.
http://www.ncbi.nlm.nih.gov/pubmed/13872969
96. Carson PE, Tarlov AR. Biochemistry of hemolysis. Annual Review of Medicine 1962;13:105-&.
http://www.ncbi.nlm.nih.gov/pubmed/13876913
97. Kellermeyer RW, Brewer GJ, Tarlov AR, Carson PE, Alving AS. Hemolytic effect of therapeutic drugs - clinical considerations of primaquine-type hemolysis. Jama-Journal of the American Medical Association 1962;180:388-&.
http://www.ncbi.nlm.nih.gov/pubmed/14454972
98. Kellermeyer RW, Tarlov AR, Brewer GJ, Carson PE, Alving AS. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis. JAMA 1962;180:388-394.
http://www.ncbi.nlm.nih.gov/pubmed/14454972
99. Tarlov AR, Brewer GJ, Carson PE, Alving AS. Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: An inborn error of metabolism of medical and biological significance. Arch Intern Med 1962;109:209-234.
http://www.ncbi.nlm.nih.gov/pubmed/13919680
100. Brewer GJ, Powell RD. Hexokinase activity as a function of age of human erythrocyte. Nature 1963;199:704-&.
http://www.ncbi.nlm.nih.gov/pubmed/14074568
101. Brewer GJ, Tarlov AR. A clinical test for galactosemia - galactose-methemoglobin test. American Journal of Clinical Pathology 1963;39:579-&.
http://www.ncbi.nlm.nih.gov/pubmed/14015352
102. Carson PE, Okita GT, Frischer H, Hirasa J, Long WK, Brewer GJ. Patterns of hemolytic susceptibility and metabolism. Proceedings of the 9th congress of the European Society of Haematology, Carson PE, Okita GT, Frischer H, Hirasa J, Long WK, Brewer GJ, editors 655-665, 1963
103. Powell RD, Alving AS, Brewer GJ. Studies on a strain of chloroquine-resistant plasmodium falciparum from colombia, south america. American Journal of Tropical Medicine and Hygiene 1963;12:509-&.
http://www.ncbi.nlm.nih.gov/pubmed/14044761
104. Powell RD, Alving AS, Degowin RL. Nitrofurantoin-induced hemolysis. Journal of Laboratory and Clinical Medicine 1963;62:1002-&.
105. Powell RD, Brewer GJ. Phosphoglyceraldehyddehydrogenase-aktivitat bei alterung menschlicher erythrocyten. Klinische Wochenschrift 1963;41:200-&.
http://www.ncbi.nlm.nih.gov/pubmed/13985831
106. Alving AS. Malaria. In: Conn HF, editor. Current therapy. Philadephia: W. B. Saunders Co.; 1964. p. 21-24.
107. Brewer GJ, Powell RD, Swanson SH, Alving AS. Hemolytic effect of primaquine. Xvii. Hexokinase activity of glucose-6-phosphate dehydrogenase-deficient and normal erythrocytes. Journal of Laboratory and Clinical Medicine 1964;64:601-612.
http://www.ncbi.nlm.nih.gov/pubmed/14233149
108. Brewer GJ, Powell RD, Tarlov AR, Alving AS. Hemolytic effect of primaquine. Xvi. Glyoxalase activity of primaquine-sensitive and normal erythrocytes. Journal of Laboratory and Clinical Medicine 1964;63:106-121.
http://www.ncbi.nlm.nih.gov/pubmed/14102892
109. Degowin RL, Powell RD. Drug-resistant falciparum malaria. Journal of Laboratory and Clinical Medicine 1964;64:851-&.
110. Powell RD, Brewer GJ. Active immunization against malaria. American Journal of Tropical Medicine and Hygiene 1964;13:228-&.
http://www.ncbi.nlm.nih.gov/pubmed/14104820
111. Powell RD, Brewer GJ, Alving AS. Studies on a strain of chloroquine-resistant plasmodium falciparum from viet nam. Proceedings of the Seventh International Congresses on Tropical Medicine and Malaria, Powell RD, Brewer GJ, Alving AS, editors 5: 10, 1964
112. Powell RD, Brewer GJ, Alving AS, Degowin RL. Activity of glyceraldehyde-3-phosphate dehydrogenase in hemolysates of normal + glucose-6-phosphate dehydrogenase-deficient erythrocytes. Journal of Clinical Investigation 1964;43:1235-&.
113. Powell RD, Brewer GJ, Alving AS, Millar JW. Studies on a strain of chloroquine-resistant plasmodium falciparum from thailand. Bulletin of the World Health Organization 1964;30:29-44.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2554896/?tool=pmcentrez
114. Powell RD, Brewer GJ, Degowin RL, Alving AS. Studies on a strain of chloroquine-resistant plasmodium falciparum from viet-nam. Bulletin of the World Health Organization 1964;31:379-392.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2555117
115. Brewer GJ, Powell RD. A study of relationship between content of adenosine triphosphate in human red cells and course of falciparum malaria - a new system that may confer protection against malaria. Proceedings of the National Academy of Sciences of the United States of America 1965;54:741-&.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC219737/?tool=pmcentrez
116. Degowin RL, Eppes RB, Powell RD, Carson PE. Studies of sulfone-induced hemolysis. Clin Res 1965;13:270.
117. Degowin RL, Powell RD. Drug resistance of a strain of plasmodium falciparum from malaya. American Journal of Tropical Medicine and Hygiene 1965;14:519-&.
118. Degowin RL, Powell RD. Effect of pyrimethamine and sulfadiazine against chloroquine-resistant plasmodium falciparum; 1965.
119. Legters LJ, Wallace DK, Powell RD, Pollack S. Apparent refractoriness to chloroquine pyrimethamine and quinine in strains of plasmodium falciparum from vietnam. Military Medicine 1965;130:168-&.
http://www.ncbi.nlm.nih.gov/pubmed/14255778
120. Powell RD. Effect of 6-methoxy-8-(5'-propylaminoamylamino)-quinoline phosphate against asexual erythrocytic forms of a strain of chloroquine-resistant plasmodium falciparum from thailand. Bulletin of the World Health Organization 1965;32:591-&.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2555268/?tool=pmcentrez
121. Powell RD, Brewer GJ. Glucose-6-phosphate dehydrogenase deficiency and falciparum malaria. American Journal of Tropical Medicine and Hygiene 1965;14:358-&.
http://www.ncbi.nlm.nih.gov/pubmed/14292739
122. Powell RD, Degowin RL. Studies on activity of pyruvate kinase in hemolysates of normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes. Annals of Internal Medicine 1965;62:1086-&.
123. Powell RD, Degowin RL. Relationship between activity of pyruvate kinase and age of normal human erythrocyte. Nature 1965;205:507-&.
http://www.ncbi.nlm.nih.gov/pubmed/14265305
124. Powell RD, Degowin RL, Eppes RB. Studies on antimalarial effects of cycloguanil pamoate (ci-501) in man. American Journal of Tropical Medicine and Hygiene 1965;14:913-&.
http://www.ncbi.nlm.nih.gov/pubmed/5320454
125. Carson PE, Frischer H. Glucose-6-phosphate dehydrogenase deficiency and related disorders of pentose phosphate pathway. American Journal of Medicine 1966;41:744-&.
126. Degowin RL, Eppes RB, Carson PE, Powell RD. Effects of diaphenylsulfone (dds) against chloroquine-resistant plasmodium falciparum. Bulletin of the World Health Organization 1966;34:671-&.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2476012/?tool=pmcentrez
127. Degowin RL, Eppes RB, Powell RD, Carson PE. Haemolytic effects of diaphenylsulfone (dds) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency. Bulletin of the World Health Organization 1966;35:165-&.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2476117/?tool=pubmed
128. Degowin RL, Frischer H. The effects of 4,4'-diaminodiphenylsulfone against chloroquine-resistant plasmodium falciparum; 1966.
129. Eppes RB, Brewer GJ, Degowin RL, Mcnamara JV, Flanagan CL, Schrier SL, Tarlov AR, Powell RD, Carson PE. Oral glucose tolerance in negro men deficient in glucose-6-phosphate dehydrogenase. New England Journal of Medicine 1966;275:855-&.
130. Eppes RB, Degowin RL, Powell RD, Legters LJ. Clinical studies with a drug-resistant strain of plasmodium falciparum from vietnam. Military Medicine 1966;131:362-&.
http://www.ncbi.nlm.nih.gov/pubmed/4955924
131. Hirsch MS, Powell RD. Malaria - a continuing problem. Ill Med J 1966;June.
132. Mcnamara JV, Eppes RB, Powell RD, Carson PE. The effects of para-aminobenzoic acid on the hemolytic effects of 4, 4'-diaminodiphenylsulfone. Military Medicine 1966;131:60.
http://www.ncbi.nlm.nih.gov/pubmed/4957810
133. Powell RD. Chemotherapy of malaria. Clinical Pharmacology & Therapeutics 1966;7:48-&.
http://www.ncbi.nlm.nih.gov/pubmed/5325586
134. Powell RD. The chemotherapy of malaria. Clin Pharm and Therap 1966;7.
135. Powell RD, Brewer GJ, Degowin RL, Carson PE. Effects of glucose-6-phosphate dehydrogenase deficiency upon host and upon host-drug-malaria parasite interactions. Military Medicine 1966;131:1039-&.
136. Powell RD, Brewer GJ, Degowin RL, Carson PE. Effects of glucose-6-phosphate dehydrogenase deficiency upon the host and upon host-drug-malaria parasite interactions. Military Medicine 1966;131:56.
137. Powell RD, Eppes RB, Mcnamara JV, Carson PE. The potential role of sulfones and sulfonamides in the prevention and treatment of infections with chloroquine-resistant plasmodium falciparum. Proceedings of the 3rd Intl Pharm Meet, Powell RD, Eppes RB, Mcnamara JV, Carson PE, editors 1: 39-43, July 1966
138. Eppes RB, Mcnamara JV, Degowin RL, Carson PE, Powell RD. Chloroquine-resistant plasmodium falciparum - protective and hemolytic effects of 4,4'-diaminodiphenylsulfone (dds) administered daily together with weekly chloroquine and primaquine. Military Medicine 1967;132:163-&.
http://www.ncbi.nlm.nih.gov/pubmed/4963120
139. Mcnamara JV, Frischer H, Rieckman.Kh, Stockert TA, Powell RD, Carson PE. Increased activity of erythrocyte glutathione reductase during administration of nicotinic acid. Journal of Laboratory and Clinical Medicine 1967;70:989-&.
140. Mcnamara JV, Rieckman.Kh, Frischer H, Stockert TA, Carson PE, Powell RD. Acquired decrease in sensitivity to quinine observed during studies with a strain of chloroquine-resistant plasmodium falciparum. Annals of Tropical Medicine and Parasitology 1967;61:386-&.
http://www.ncbi.nlm.nih.gov/pubmed/4947654
141. Mcnamara JV, Rieckman.Kh, Powell RD. Pigment in asexual erythrocytic forms of chloroquine-resistant plasmodium falciparum. Annals of Tropical Medicine and Parasitology 1967;61:125-&.
http://www.ncbi.nlm.nih.gov/pubmed/4863390
142. Powell RD, Brewer GJ. Effects of pyrimethamine chlorguanide and primaquine against exoerythrocytic forms of a strain of chloroquine-resistant plasmodium falciparum from thailand. American Journal of Tropical Medicine and Hygiene 1967;16:693-&.
http://www.ncbi.nlm.nih.gov/pubmed/4864054
143. Powell RD, Degowin RL, Eppes RB, Mcnamara JV, Carson PE. The antimalarial and hemolytic properties of 4,4-diaminodiphenyl sulfone (dds). International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1967;35:590-604.
http://www.ncbi.nlm.nih.gov/pubmed/4869693
144. Powell RD, Degowin RL, Mcnamara JV. Clinical experience with sulphadiazine and pyrimethamine in treatment of persons experimentally infected with chloroquine-resistant plasmodium falciparum. Annals of Tropical Medicine and Parasitology 1967;61:396-&.
http://www.ncbi.nlm.nih.gov/pubmed/4947655
145. Frischer H, Mcnamara JV, Rieckmann KH, Stockert TA, Powell RD, Carson PE. H2o2 effects on intracellular enzymes and glutathione (gsh); activation of glutathione reductase (gssg-r). Clin Res 1968;16:303.
146. Mcnamara JV, Rieckmann KH, Stockert TA, Frischer H, Carson PE, Powell RD. Clinical studies on chloroquine-resistant plasmodium falciparum. La Clinica terapeutica 1968;44:389-404.
http://www.ncbi.nlm.nih.gov/pubmed/4903977
147. Powell RD. Drug resistance of parasites causing human malaria. Annual Review of Medicine 1968;19:81-&.
http://www.ncbi.nlm.nih.gov/pubmed/4871697
148. Rieckman.Kh, Brewer GJ, Powell RD. Effects of diaphenylsulphone (dapsone) against plasmodium vivax of south west pacific origin. Transactions of the Royal Society of Tropical Medicine and Hygiene 1968;62:649-&.
149. Rieckmann KH, Mcnamara JV, Frischer H, Stockert TA, Carson PE, Powell RD. Effects of chloroquine quinine and cycloguanil upon maturation of asexual erythrocytic forms of 2 strains of plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene 1968;17:661-&.
150. Rieckman.Kh, Mcnamara JV, Frischer H, Stockert TA, Carson PE, Powell RD. Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of plasmodium falciparum. Bulletin of the World Health Organization 1968;38:625-&.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2554527/?tool=pubmed
151. Rieckman.Kh, Mcnamara JV, Kass L, Powell RD. Gametocytocidal and sporontocidal effects of primaquine upon 2 strains of plasmodium falciparum. Military Medicine 1969;134:802-&.
http://www.ncbi.nlm.nih.gov/pubmed/4987059
152. Rieckman.Kh, Mcnamara JV, Powell RD. Effects of quinine and of chloroquine in vitro against a strain of chloroquine-resistant plasmodium falciparum that displays a relative resistance to quinine in vivo. Military Medicine 1969;134:795-&.
http://www.ncbi.nlm.nih.gov/pubmed/4987058
153. Rieckman.Kh, Powell RD, Mcnamara JV, Willerso.D, Kass L, Frischer H, Carson PE. Effects of tetracycline against chloroquine-resistant and chloroquine-sensitive plasmodium-falciparum. American Journal of Tropical Medicine and Hygiene 1971;20:811-&.
http://www.ncbi.nlm.nih.gov/pubmed
154. Powell RD, Mcnamara JV, Rieckman.Kh. Clinical aspects of acquisition of immunity to falciparum malaria. Proceedings of the Helminthological Society of Washington 1972;39:51-66.
* This bibliography is not necessarily comprehensive and may contain some duplicate references.